Outcomes on Social and Classic Cognition in adults with Pediatric-onset Multiple Sclerosis

Mult Scler Relat Disord. 2021 Aug:53:103071. doi: 10.1016/j.msard.2021.103071. Epub 2021 Jun 8.

Abstract

Background: Cognitive impairment affecting classic and social domains has been consistently reported in patients with Multiple Sclerosis (MS). However, little is known about the cognitive outcomes, particularly on social cognition, in adults with pediatric-onset multiple sclerosis (POMS).

Objectives: To compare the performance in classic and social cognitive domains between adults with POMS and adult-onset MS (AOMS).

Methods: A group of 30 patients with POMS (age onset <18 years) was compared with age-matched (AOAMS, n=30) and disease duration-matched (AODMS, n= 30) patients who developed MS after the age of 18 years. Cognitive performance was assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and Theory of Mind (ToM) tests.

Results: Cognitive impairment was more prevalent in POMS patients (40% vs. 16.7%, p=0.045), independently of age or disease duration, affecting more severely information-processing speed and visual memory domains. No statistically significant differences were found in ToM performance between patients with POMS and AOMS. When analyzing ToM performance according to age of disease onset (≤15 years; 15-20 years; ≥20 years), patients with disease onset ≤15 years old had significantly lower scores on ToM tests when compared to the other groups.

Conclusion: Patients with POMS were more prone to develop impairment on classic cognitive domains than on ToM ability, when compared with AOMS patients. The interference of POMS with critical neurodevelopmental periods, specific for each cognitive domain, may explain different outcomes at adulthood on social and classic cognition.

Keywords: Cognitive impairment; Multiple Sclerosis; Pediatric Onset; Social Cognition; Theory of Mind.

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Child
  • Cognition
  • Cognitive Dysfunction* / epidemiology
  • Cognitive Dysfunction* / etiology
  • Humans
  • Multiple Sclerosis* / complications
  • Multiple Sclerosis* / epidemiology
  • Neuropsychological Tests
  • Theory of Mind*